Singular Genomics to Present at the Gilmartin Group Emerging Growth Company Showcase
08 9월 2023 - 9:00PM
Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company
leveraging novel next-generation sequencing (NGS) and multiomics
technologies to empower researchers and clinicians, today announced
plans to participate in the virtual Gilmartin Group Emerging Growth
Company Showcase.
Singular Genomics’ management is scheduled to present on
Thursday, September 21, 2023, at 8:30 a.m. Pacific Time /
11:30 a.m. Eastern Time. Investors and other interested parties are
invited to listen to a live and recorded webcast of the
presentation at investor.singulargenomics.com, in the Presentations
& Events section.
About Singular Genomics Systems, Inc.
Singular Genomics is a life science technology
company that develops next-generation sequencing and multiomics
technologies. The commercially available G4 Sequencing Platform is
a powerful, highly versatile benchtop genomic sequencer designed to
produce fast and accurate results. In development, the PX system
leverages Singular’s proprietary sequencing technology, applying it
as an in situ readout to look at RNA and proteins in single cells
and tissue. With these products, Singular Genomics’ mission is to
empower researchers and clinicians to advance science and medicine.
Visit www.singulargenomics.com for more information.
Investor ContactMatt
Clawson949-370-8500ir@singulargenomics.com
Media ContactDan Budwick,
1AB973-271-6085dan@1abmedia.com
Singular Genomics Systems (NASDAQ:OMIC)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024
Singular Genomics Systems (NASDAQ:OMIC)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024